Evan Rieder
Procedural Dermatology · New York, NYNPI 1376718809
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $183,415 of the $210,391 with a category attached, or 87.2%. 25 manufacturers reported payments, led by AbbVie at 32.0% of the total. 2025 is the largest year on record at $83,564, more than ten times the $6,618 reported in 2019. Among procedural dermatology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 116 payments — averaging $1813.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$67K
- Merz North America, Inc.$56K
- UCB SA$48K
- Revance Therapeutics, Inc.$20K
- UCB Biosciences Inc.$13K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$5K
- plus $2K from 19 others
Across 8 payments — averaging $1218.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$10K
What the payments were for
- Consulting fees$183,41587%
- Speaking & faculty fees$19,5009%
- Travel & lodging$4,8412%
- Food & beverage$2,6351%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $67,386 |
| Merz North America, Inc. | 10 | $55,968 |
| UCB SA | 8 | $48,375 |
| Revance Therapeutics, Inc. | 5 | $19,709 |
| UCB Biosciences Inc. | 3 | $12,750 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $4,686 |
| Regeneron Healthcare Solutions, Inc. | 8 | $214 |
| Sun Pharmaceutical Industries Inc. | 9 | $193 |
| Amgen | 9 | $192 |
| Johnson & Johnson | 9 | $190 |
| Pfizer | 7 | $137 |
| Galderma Laboratories, L.p. | 1 | $110 |
| Incyte Corporation | 4 | $89 |
| Almirall LLC | 3 | $70 |
| E.r. Squibb & Sons, L.L.C. | 2 | $44 |
| Arcutis Biotherapeutics, Inc. | 2 | $44 |
| Viiv Healthcare Company | 1 | $34 |
| Dermavant Sciences, Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $29 |
| Sanofi | 1 | $28 |
| Mayne Pharma Commercial LLC | 2 | $24 |
| Novartis | 1 | $23 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $23 |
| Novo Nordisk | 1 | $21 |
| Journey Medical Corporation | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAXXIFY$19,500
- BOTOX COSMETIC$11,050
- Bimzelx$10,325
- BOTOX$10,200
- Bimekizumab$6,450
- ARAZLO$4,550
- XEOMIN$140
- AKLIEF$110
How this compares
$210,391 in reported general payments places this provider in the 90th percentile of 69 procedural dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 12 | $159 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in New York
- Michelle HenryNew York$460K
- Jerry ShapiroNew York$414K
- Dendy EngelmanNew York$292K
- Daniel Belkin-HollandNew York$208K
- Ariel OstadNew York$36K
- Elizabeth HaleNew York$34K
- Heidi WaldorfNew York$29K
- Robert FinneyNew York$19K
- Shera AranoffNew York$8K
- Lisa RothmanNew York$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.